| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |